Key result
Etomidate for anesthesia induction resulted in similar outcomes for mortality and length of hospital stay compared to other drugs in patients undergoing major cardiac surgery.
Why the study?
Does etomidate for anesthesia induction improve or worsen clinical outcomes in patients ahead of major cardiac surgery?
Population
3,054 patients ahead of major cardiac surgery
Comparison
Etomidate for anesthesia induction vs Other drugs for anesthesia induction
Design
Editorial
Authors
Loading...
Etomidate appears to be a safe and hemodynamically stable option for anesthesia induction in major cardiac surgery, with no evidence of worse clinical outcomes compared to other agents despite concerns regarding transient adrenal suppression.
Does etomidate for anesthesia induction improve or worsen clinical outcomes in patients ahead of major cardiac surgery?
Etomidate appears to be a safe and hemodynamically stable option for anesthesia induction in major cardiac surgery, with no evidence of worse clinical outcomes compared to other agents despite concerns regarding transient adrenal suppression.
Jong et al. (2014) conducted an editorial in Major cardiac surgery (n=3,054). Etomidate vs. Other anesthesia induction drugs was evaluated on Mortality and length of hospital stay. Etomidate for anesthesia induction resulted in similar outcomes for mortality and length of hospital stay compared to other drugs in patients undergoing major cardiac surgery.